Skip to main content
OpenTrials

Clinical trial condition

Hemophilia A

Explore clinical trials studying Hemophilia A. Study availability and eligibility vary by location and protocol.

281 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia A trial results

Completed

A Study of ADVATE in People With Hemophilia A in India

NCT04985682

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Amrita Institute of Medical Science & Research Centre Ernākulam, Kerala, India
  • St. John's Medical College Bengaluru, India
  • K J Somaiya Hospital & Research Centre Mumbai, India
  • All India Institute of Medical Sciences (AIIMS) New Delhi, India
View Trial Details
Completed

Post Marketing Surveillance Study for ADYNOVATE in South Korea

NCT03824522

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Kyungpook National University Chilgok Hospital Daegu, South Korea
  • Kyungpook National University Hospital Daegu, South Korea
  • Daegu Catholic University Medical Center Daegu, South Korea
  • Severance Hospital Yonsei University Health System Seoul, South Korea
View Trial Details
Completed

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

NCT04456387

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Capital Medical University affiliated Beijing Children's Hospital Beijing, Beijing Municipality, China
  • Chongqing Three Gorges Central Hospital Chongqing, Chongqing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
View all 17 locations
View Trial Details
Completed

Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A

NCT04845399

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Capital Medical University affiliated Beijing Children's Hospital Beijing, Beijing Municipality, China
  • Chongqing Three Gorges Central Hospital Chongqing, Chongqing Municipality, China
  • The First Hospital of Lanzhou University Lanzhou, Gansu, China
View all 16 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Pharmacokinetic of Recombinant Human Coagulation Factor VIII ，Fc Fusion Protein for Injection

NCT05251090

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Beijing Children's Hospital,Capital Medical University Beijing, Beijing Municipality, China
  • Shenzhen Children's Hospita Shenzhen, Guangdong, China
  • Nanfang Hospital of Southern Medical University Guangzhou, China
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei, China
View Trial Details
Completed

Study to Gain More Information on How Safe and Effective Jivi Works in Patients With Severe Hemophilia A (Post-marketing Investigation)

NCT04085458

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • UMHAT Tsaritsa Joanna-ISUL EAD Sofia Sofia, Bulgaria
  • MHAT Sveta Marina EAD Varna, Bulgaria
  • Aarhus Universitetshospital, Skejby Arhus N, Denmark
  • LAIKO General Hospital of Athens Athens, Greece
View all 13 locations
View Trial Details

Related conditions